<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Hallenbeck, John</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New and Old Targets for Acute Intervention: From Science to the Clinic</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">5-6</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses the scientific and clinical targets for acute intervention including immunomodulation, the benefits of direct thrombolytic plasmin, the use of activated protein C for chronic neurodegenerative disorders, as well as strategies to modify the endothelial hemostatic-thrombotic balance to treat stroke.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>